I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hutmacher, MM
13
results:
Search for persons
X
Format
Online (13)
Mediatypes
Articles (Online) (6)
OpenAccess-fulltext (7)
Sorted by: Relevance
Sorted by: Year
?
1
Model‐Informed Development and Registration of a Once‐Daily..:
Lamba, M
;
Hutmacher, MM
;
Furst, DE
...
Clinical Pharmacology & Therapeutics. 101 (2017) 6 - p. 745-753 , 2017
Link:
https://doi.org/10.1002/..
?
2
Evaluating Dosage Optimality for Tofacitinib, an Oral Janus..:
Hutmacher, MM
;
Papp, K
;
Krishnaswami, S
...
CPT: Pharmacometrics & Systems Pharmacology. 6 (2017) 5 - p. 322-330 , 2017
Link:
https://doi.org/10.1002/..
?
3
Population Exposure‐Response Modeling of Naloxegol in Patie..:
Al‐Huniti, N
;
Nielsen, JC
;
Hutmacher, MM
...
CPT: Pharmacometrics & Systems Pharmacology. 5 (2016) 7 - p. 359-366 , 2016
Link:
https://doi.org/10.1002/..
?
4
Evaluating the Use of Linear Mixed‐Effect Models for Infere..:
Huh, Y
;
Hutmacher, MM
CPT: Pharmacometrics & Systems Pharmacology. 4 (2015) 1 - p. 1-9 , 2015
Link:
https://doi.org/10.1002/..
?
5
Exposure-response Analysis for Spontaneously Reported Dizzi..:
Ito, K
;
Hutmacher, MM
;
Liu, J
...
Clinical Pharmacology & Therapeutics. 84 (2008) 1 - p. 127-135 , 2008
Link:
https://doi.org/10.1038/..
?
6
Modeling and Simulation to Support Dose Selection and Clini..:
Kowalski, KG
;
Olson, S
;
Remmers, AE
.
Clinical Pharmacology & Therapeutics. 83 (2007) 6 - p. 857-866 , 2007
Link:
https://doi.org/10.1038/..
?
7
Evaluating Dosage Optimality for Tofacitinib, an Oral Janus..:
Hutmacher, MM
;
Papp, K
;
Krishnaswami, S
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445230/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
8
Model‐Informed Development and Registration of a Once‐Daily..:
Lamba, M
;
Hutmacher, MM
;
Furst, DE
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485720/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
9
Evaluating the Use of Linear Mixed-Effect Models for Infere..:
Huh, Y
;
Hutmacher, MM
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2015
Link:
http://www.ncbi.nlm.nih...
?
10
Population pharmacokinetics of pegaptanib sodium (Macugen®)..:
Basile AS
;
Hutmacher MM
;
Kowalski KG
..
http://www.dovepress.com/population-pharmacokinetics-of-pegaptanib-sodium-macugenreg-in-patient-peer-reviewed-article-OPTH. , 2015
Link:
https://doaj.org/article..
?
11
Tissue engineering cartilage with deep zone cytoarchitectur..:
Armstrong, JP
;
Pchelintseva, E
;
Treumuth, S
...
Advanced Healthcare Materials. , 2022
Link:
http://hdl.handle.net/10..
?
12
Research data supporting "Engineering anisotropic muscle ti..:
Armstrong, JPK
;
Puetzer, JL
;
Serio, A
...
doi:10.1002/adma.201802649. , 2018
Link:
https://zenodo.org/recor..
?
13
Cavin-1/PTRF alters prostate cancer cell-derived extracellu..:
Inder, KL
;
Ruelcke, JE
;
Petelin, L
...
issn:2001-3078. , 2014
Link:
http://hdl.handle.net/11..
1-13
